Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-29 @ 11:25 PM
Study NCT ID:
NCT01492504
Status:
COMPLETED
Last Update Posted:
2019-11-27
First Post:
2011-11-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-30
First Submit QC Date:
None
Study First Post Date:
2011-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-26
Last Update Post Date:
2019-11-27
Last Update Post Date Type:
ACTUAL